• Naoshi Takeyama, Hiroshi Noguchi, Akihiko Hirakawa, Hideki Kano, Kazuma Morino, Toru Obata, Tetsuya Sakamoto, Fumihiro Tamai, Hiroyasu Ishikura, Youichi Kase, Makoto Kobayashi, Toshio Naka, Yoshiki Takahashi, and Japan Sepsis Study Group.
• Department of Emergency and Acute Intensive Care Medicine, Fujita Health University, Toyoake, Aichi 470-1192, Japan. takeyama@fujita-hu.ac.jp
• Blood Purif. 2012 Jan 1;33(4):252-6.

BackgroundWe investigated whether early initiation of hemoperfusion with a polymyxin B cartridge (PMX) after the diagnosis of septic shock could improve the clinical outcome.MethodsA prospective, open-labeled, multicenter cohort study was performed at intensive care units in Japan. 41 patients received PMX within 6 h after the diagnosis of septic shock (early group) and 51 patients were treated after 6 h (late group).ResultsThe early group had a significantly shorter duration of ventilator support and also had a lower catecholamine requirement. PMX was effective for improvement of hypotension, hypoperfusion, the sequential organ failure assessment score, and pulmonary oxygenation regardless of the timing of its initiation. The 28-day mortality rate did not differ between the two groups.ConclusionsEarly initiation of PMX shortened the duration of ventilator support and also reduced the catecholamine requirement, so early treatment of septic shock should achieve a better outcome.Copyright © 2012 S. Karger AG, Basel.

23 keywords...

hide…